-->

11/27/2018

Five key takeaways from ASCO, the world's largest cancer research conference

CNBC Asia "This should spare a lot more folks from chemo that won't really have much benefit." -Doug Schenkel., Cowen analyst
at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

We're witnessing a new Mark Zuckerberg. Welcome to Zuck 3.0.

Mark Zuckerberg has shown himself to be the ultimate Silicon Valley shape-shifter, and in the first couple of weeks of 2025, we got our bes...